A Study of MHB036C Combined With MHB039A in Patients With Advanced Breast Cancer or Other Advanced Malignant Solid Tumors

NCT07130383 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

210

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Breast Cancer
Advanced Malignant Solid Tumor

Interventions

DRUG: MHB036C for Injection
DRUG: MHB039A for Injection

Sponsor

Minghui Pharmaceutical (Hangzhou) Ltd